The administration of rapamycin, an mTOR inhibitor, showed an augmentation of ALS disease progression39, whereas increased phosphorylation levels of AKT promoted survival in the hG93A-SOD1 model26,40. This evidence concerns the gene AKT1 and amyotrophic lateral sclerosis.